• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工心脏模型:方向与挑战。

Engineered models of the human heart: Directions and challenges.

机构信息

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands; Department of Applied Stem Cell Technologies, University of Twente, Enschede 7500AE, the Netherlands.

出版信息

Stem Cell Reports. 2021 Sep 14;16(9):2049-2057. doi: 10.1016/j.stemcr.2020.11.013. Epub 2020 Dec 18.

DOI:10.1016/j.stemcr.2020.11.013
PMID:33338434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8452488/
Abstract

Human heart (patho)physiology is now widely studied using human pluripotent stem cells, but the immaturity of derivative cardiomyocytes has largely limited disease modeling to conditions associated with mutations in cardiac ion channel genes. Recent advances in tissue engineering and organoids have, however, created new opportunities to study diseases beyond "channelopathies." These synthetic cardiac structures allow quantitative measurement of contraction, force, and other biophysical parameters in three-dimensional configurations, in which the cardiomyocytes in addition become more mature. Multiple cardiac-relevant cell types are also often combined to form organized cardiac tissue mimetic constructs, where cell-cell, cell-extracellular matrix, and paracrine interactions can be mimicked. In this review, we provide an overview of some of the most promising technologies being implemented specifically in personalized heart-on-a-chip models and explore their applications, drawbacks, and potential for future development.

摘要

目前,人们广泛使用人类多能干细胞来研究人类心脏(病理)生理学,但衍生的心肌细胞的不成熟在很大程度上限制了疾病模型的建立,只能用于与心脏离子通道基因突变相关的疾病。然而,组织工程和类器官的最新进展为研究超越“通道病”的疾病创造了新的机会。这些合成心脏结构允许在三维构型中定量测量收缩、力和其他生物物理参数,其中心肌细胞也变得更加成熟。多种与心脏相关的细胞类型通常也组合在一起,形成有组织的心脏组织模拟构建体,其中可以模拟细胞-细胞、细胞-细胞外基质和旁分泌相互作用。在这篇综述中,我们提供了一些最有前途的技术的概述,这些技术专门应用于个性化的芯片上心脏模型,并探讨了它们的应用、缺点和未来发展的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eec8/8452488/d09f733a6e74/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eec8/8452488/22443a4cf7a8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eec8/8452488/d09f733a6e74/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eec8/8452488/22443a4cf7a8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eec8/8452488/d09f733a6e74/gr2.jpg

相似文献

1
Engineered models of the human heart: Directions and challenges.人工心脏模型:方向与挑战。
Stem Cell Reports. 2021 Sep 14;16(9):2049-2057. doi: 10.1016/j.stemcr.2020.11.013. Epub 2020 Dec 18.
2
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.基于人诱导多能干细胞(hiPSC)分化的心肌细胞和心脏细胞外基质构建的工程化心脏组织模型,可用于疾病建模和药物测试应用。
Acta Biomater. 2019 Jul 1;92:145-159. doi: 10.1016/j.actbio.2019.05.016. Epub 2019 May 7.
3
Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.人诱导多能干细胞衍生的心肌细胞、3D心脏结构和芯片心脏作为药物研究工具。
Pflugers Arch. 2021 Jul;473(7):1061-1085. doi: 10.1007/s00424-021-02536-z. Epub 2021 Feb 24.
4
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration.从干细胞到心脏组织:走向成熟和心脏再生的新途径。
Circ Res. 2021 Mar 19;128(6):775-801. doi: 10.1161/CIRCRESAHA.121.318183. Epub 2021 Mar 18.
5
"The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells.“心脏的状态”:从多能干细胞构建人类心脏组织的最新进展
Exp Biol Med (Maywood). 2015 Aug;240(8):1008-18. doi: 10.1177/1535370215589910. Epub 2015 Jun 10.
6
Advances in cardiac tissue engineering and heart-on-a-chip.心脏组织工程学和芯片上心脏的研究进展。
J Biomed Mater Res A. 2024 Apr;112(4):492-511. doi: 10.1002/jbm.a.37633. Epub 2023 Nov 1.
7
Engineered platforms for mimicking cardiac development and drug screening.用于模拟心脏发育和药物筛选的工程平台。
Cell Mol Life Sci. 2024 Apr 25;81(1):197. doi: 10.1007/s00018-024-05231-1.
8
Reconstructing the heart using iPSCs: Engineering strategies and applications.使用 iPS 细胞重建心脏:工程策略与应用。
J Mol Cell Cardiol. 2021 Aug;157:56-65. doi: 10.1016/j.yjmcc.2021.04.006. Epub 2021 Apr 22.
9
I-Wire Heart-on-a-Chip I: Three-dimensional cardiac tissue constructs for physiology and pharmacology.I型线控芯片心脏I:用于生理学和药理学研究的三维心脏组织构建体
Acta Biomater. 2017 Jan 15;48:68-78. doi: 10.1016/j.actbio.2016.11.009. Epub 2016 Nov 4.
10
Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue.机械应力调节和电刺激促进诱导多能干细胞来源的人类心脏组织的收缩性和力成熟。
Circulation. 2016 Nov 15;134(20):1557-1567. doi: 10.1161/CIRCULATIONAHA.114.014998. Epub 2016 Oct 13.

引用本文的文献

1
Cardiac Tissue Bioprinting: Integrating Structure and Functions Through Biomimetic Design, Bioinks, and Stimulation.心脏组织生物打印:通过仿生设计、生物墨水和刺激整合结构与功能
Gels. 2025 Jul 31;11(8):593. doi: 10.3390/gels11080593.
2
FORCETRACKER: A versatile tool for standardized assessment of tissue contractile properties in 3D Heart-on-Chip platforms.FORCE追踪器:一种用于在3D芯片上心脏平台中对组织收缩特性进行标准化评估的多功能工具。
PLoS One. 2025 Feb 13;20(2):e0314985. doi: 10.1371/journal.pone.0314985. eCollection 2025.
3
Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations.

本文引用的文献

1
Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease.人诱导多能干细胞衍生的心脏基质细胞增强 3D 心脏微组织的成熟,并揭示非心肌细胞对心脏疾病的贡献。
Cell Stem Cell. 2020 Jun 4;26(6):862-879.e11. doi: 10.1016/j.stem.2020.05.004. Epub 2020 May 26.
2
Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency.在人类工程心脏组织中分析力和钙离子瞬变揭示了生理频率下的正力频率关系。
Stem Cell Reports. 2020 Feb 11;14(2):312-324. doi: 10.1016/j.stemcr.2019.12.011. Epub 2020 Jan 16.
3
推进用于心力衰竭研究的3D工程体外模型:关键特征与注意事项
Bioengineering (Basel). 2024 Dec 3;11(12):1220. doi: 10.3390/bioengineering11121220.
4
Multicellular 3D models to study myocardial ischemia-reperfusion injury.用于研究心肌缺血再灌注损伤的多细胞3D模型。
Front Cell Dev Biol. 2024 Nov 15;12:1494911. doi: 10.3389/fcell.2024.1494911. eCollection 2024.
5
The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity.现实心脏模型在疾病建模和心脏毒性研究中的应用现状。
Int J Mol Sci. 2024 Aug 24;25(17):9186. doi: 10.3390/ijms25179186.
6
Insulin-Activated Signaling Pathway and GLUT4 Membrane Translocation in hiPSC-Derived Cardiomyocytes.人诱导多能干细胞衍生心肌细胞中的胰岛素激活信号通路和 GLUT4 膜转位。
Int J Mol Sci. 2024 Jul 27;25(15):8197. doi: 10.3390/ijms25158197.
7
Hypoxia and re-oxygenation effects on human cardiomyocytes cultured on polycaprolactone and polyurethane nanofibrous mats.缺氧和复氧对在聚己内酯和聚氨酯纳米纤维垫上培养的人心肌细胞的影响。
J Biol Eng. 2024 Jun 6;18(1):37. doi: 10.1186/s13036-024-00432-5.
8
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.心脏疾病的临床前模型:临床科学家的综合概述。
Cardiovasc Eng Technol. 2024 Apr;15(2):232-249. doi: 10.1007/s13239-023-00707-w. Epub 2024 Jan 16.
9
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy.生理应激改善营养不良性心肌病的干细胞建模。
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050487. Epub 2024 Feb 5.
10
Biotechnological advances and applications of human pluripotent stem cell-derived heart models.人类多能干细胞衍生心脏模型的生物技术进展与应用
Front Bioeng Biotechnol. 2023 Jul 25;11:1214431. doi: 10.3389/fbioe.2023.1214431. eCollection 2023.
European Society of Cardiology: Cardiovascular Disease Statistics 2019.
欧洲心脏病学会:《2019年心血管疾病统计数据》
Eur Heart J. 2020 Jan 1;41(1):12-85. doi: 10.1093/eurheartj/ehz859.
4
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.肌动蛋白 2 突变的疾病建模指导肥厚型心肌病的临床治疗。
EMBO Mol Med. 2019 Dec;11(12):e11115. doi: 10.15252/emmm.201911115. Epub 2019 Nov 3.
5
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue.慢性间歇性光遗传学起搏诱导人心工程组织心律失常易损性。
Cardiovasc Res. 2020 Jul 1;116(8):1487-1499. doi: 10.1093/cvr/cvz245.
6
Engineering of human cardiac muscle electromechanically matured to an adult-like phenotype.将人心肌工程化,使其电机械成熟为成人样表型。
Nat Protoc. 2019 Oct;14(10):2781-2817. doi: 10.1038/s41596-019-0189-8. Epub 2019 Sep 6.
7
Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications.人多能干细胞衍生的心血管细胞:从发育生物学到治疗应用。
Cell Stem Cell. 2019 Sep 5;25(3):311-327. doi: 10.1016/j.stem.2019.07.010.
8
Biowire Model of Interstitial and Focal Cardiac Fibrosis.间质和局灶性心脏纤维化的生物线模型
ACS Cent Sci. 2019 Jul 24;5(7):1146-1158. doi: 10.1021/acscentsci.9b00052. Epub 2019 Jun 4.
9
Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue.从工程化人心组织看儿茶酚胺多形性室性心动过速的发病机制。
Circulation. 2019 Jul 30;140(5):390-404. doi: 10.1161/CIRCULATIONAHA.119.039711. Epub 2019 Jul 17.
10
Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis.从人诱导多能干细胞中生成静止心肌成纤维细胞,用于体外建模心脏纤维化。
Circ Res. 2019 Aug 16;125(5):552-566. doi: 10.1161/CIRCRESAHA.119.315491. Epub 2019 Jul 10.